Avaliação dos marcadores de prognóstico Ki-67, p53 no tumor mamário maligno de cadelas

Autores

  • Ana Carolina Trompieri-Silveira Universidade Federal de Sergipe
  • Geórgia Modé Magalhães Universidade Federal de Sergipe
  • Antonio Carlos Alessi Universidade Estadual Paulista

DOI:

https://doi.org/10.22256/pubvet.v6n16.1361

Palavras-chave:

Neoplasia; tumor de mama; cadela; marcadores; prognóstico.

Resumo

Tendo em vista a elevada incidência das neoplasias mamárias nas cadelas, este trabalho teve como objetivo investigar os marcadores de prognóstico nos tumores malignos caninos. Para a realização deste estudo foram selecionadas 30 amostras de tumores mamários de cadelas. As amostras foram divididas em 3 grupos, de acordo com a classificação histopatológica sendo, carcinossarcoma, carcinoma sólido, carcinoma tubulopapilar. A avaliação dos marcadores de prognóstico Ki-67, p53, foi conduzida por imuno-histoquímica, utilizando-se a técnica estreptoavidina-biotina-peroxidase. Para o Ki-67 a diferença significativa foi vista entre o carcinoma sólido e carcinoma tubulopapilar. O gene p53 apresentou diferença significativa (P<0,05) entre a imunorreatividade do carcinossarcoma e do carcinoma sólido e tubulopapilar. 

Referências

BENJAMIN, S. A.; LEE, A. C.; SAUNDERS, W. J. Classification and behavior of canine mammary epithelial neoplasms based on life-span observations in beagles. Veterinary Pathology, v. 36, p. 423-436, 1999.

COTRAN, R. S.; KUMAR, V.; COLLINS, T. Robbins Patologia Estrutural e Funcional. 6. ed. Rio de Janeiro: Guanabara Koogan, 2000. p. 979-1002.

GASPARINI, G.; BORACCHI, P.; VERDEIRO, P.; BEVILACQUA, P. Cell kinetics in human breast câncer: comparison between the prognostic value of the cytofluorimetric S-phase fraction and that of the antibodies Ki-67 and PCNA antigens detected by immunocytochemistry. International Journal of Cancer, v. 57, p. 822-829, 1994.

GERDES, J.; ZENTGRAF, H. Ki67/MIB1 immunostaining in tumor pathology. European Journal of Histology, v. 42, p.15, 1998.

LEE, C. H.; KIM, W. H.; LIM, J. H.; KANG, M. S.; KIM, D. Y.; KWEON, O. K. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. Journal of Veterinary Science, v. 5, n. 1, p.63-69, 2004.

LOWE, S. W.; BODIS, S.; MACCLATCHEY, A. P53 status and the efficacy of cancer therapy in vivo. Science, n. 266, p. 807-810, 1994.

MARTÍN de LAS MULAS, J.; MILLÁN, Y.; DIOS, R. A prospective analysis of immunohistochemically determined estrogen receptor  and progesterone receptor expression and host ant tumor factors as predictors of disease-free period in mammary gland of the dog. Veterinary Pathology, v.42, p. 200-212, 2005.

MAY, P.; MAY, E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene, v. 8, p. 7621-7636, 1999.

MAYR, B.; DRESSLER, A.; REIFINGER, M.; FEIL, C. Cytogenetic alterations in eight mammary tumors and tumor-supressor gene p-53 mutation in one mammary tumor from dogs. American Journal of Veterinary Research, v.59, p. 69-78, 1998.

MILLANTA, F.; CALANDRELLA, M.; BARI, G.; NICCOLINI, M.; VANNOZZI, I.; POLI, A. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Research in Veterinary Science, v.79, p. 225-232, 2005.

MILLANTA, F.; CITI, S.; DELLA SANTA, D.; PORCIANI, M.; POLI, A. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers. Breast Cancer Research and Treatment, v. 98, n. 1, p. 115-120, 2006.

MISDORP, W.; ELSE, R. W.; HELLMÉN, E. Histological classification of mammary tumors of the dog and the cat. Armed Forces Institute of Pathology, v. 7, n. 1, p.1-59, 1999.

MOULTON, J. E. Tumors of the mammary gland. In:____. Tumors in Domestic Animals. 3. ed. Los Angeles: University of California Press, 1990. Cap. 12, p. 518-552.

NIETO, A.; PENA, L.; PEREZ-ALENZA, M. D.; SANCHEZ, M. A.; FLORES, J. M.; CASTANO, M. Immunohistochemical detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Veterinary Pathology, v. 37, p. 239-247, 2000.

O´REILLY, S. M.; RICHARDS, M. A: Clinical aspects of assessing cell proliferation. In: Assessment of Cell Proliferation in Clinical Practice, ed. Hall PA, Levison DA, and Wright NA, pp. 63-79. Springer, London, UK, 1992.

PEÑA, L. L.; NIETO, A. I.; PÉREZ-ALENZA, D.; CUESTA, P.; CASTAÑO, M. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: Relationship to clinical and pathologic variables. Journal of Veterinary Diagnostic Investigation, v. 10, n. 3, p. 237-346, 1998.

RUNGSIPIPAT, A.; TATEYAMA, S.; YAMAGUCHI, R.; UCHIDA, K.; MIYOSHI, N.; HAYASHI, T. Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors. Journal of Veterinary Medical Science, v. 61, p. 27-32, 1999.

RUTTEMAN, G. R.; WITHROW, S. J.; MACEWEN, E. G. Tumors of the mammary gland. In: Small animal clinical oncology. 3 ed. Philadephia: Saunders., 2001, p. 455-467.

SAKAI, H.; NODA, A.; SHIRAI, N.; TIDAKA, T.; YANAI, T.; MASEGI, T. Proliferative Activity of Canine Mast Cell Tumors Evaluated by Bromodeoxyuridine Incorporation and Ki-67 Expression. Journal of Comparative Pathology, v. 127, n. 4, p. 233-238, 2002.

VELDHOEN, N.; WATTERSON, J.; BRASH, M.; MILNER, J. Identification of tumor-associated and germ line p53 mutations in canine mammary cancer. British Journal of Cancer, v. 81, p. 409-415, 1999.

YANG, W. Y.; LIU, C. H.; CHANG, C. J.; LEE, C. C.; CHANG, K. J.; LIN, C. T. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumors. Journal of Comparative Pathology, v. 134, p. 70-79, 2006.

WU, H.; HAYASHI, T.; INOUE, M. Immunohistochemical expression of Mdm2 and p53 in canine cutaneous mast cell tumours. Journal of Veterinary Medicine – A Physiology, Pathology, Clinical Medicine, v. 53, n. 2, p. 65-68, 2006.

ZACCHETTI, A.; VAN GARDEREN, E.; TESKE, E.; NEDERBRAGT, H.; DIERENDONCK, J. H.; RUTTEMAN, G. R. Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of Ki-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labeling by immunohistochemistry. Acta Pathologica, microbiologica et Immunologica, v. 111, p. 430-438, 2003.

ZUCCARI, D. A. P. C.; TERZIAN, A. C. B. ; PEREIRA, R. S.; PAVAM, M. V.; RUIZ, C. M.; UEIRO, F. A. R.; ANDRADE, J. C. A.; CORDEIRO, J. A. Avaliação imunohistoquímica do gene p53 nas neoplasias mamárias caninas. ARS Veterinária, v. 21, n. 3, p. 344-350, 2005.

Downloads

Publicado

29-11-2015

Edição

Seção

Medicina veterinária

Como Citar

Avaliação dos marcadores de prognóstico Ki-67, p53 no tumor mamário maligno de cadelas. (2015). Pubvet, 6(16), e1361. https://doi.org/10.22256/pubvet.v6n16.1361

Artigos mais lidos pelo mesmo(s) autor(es)